Provention Bio, Inc. IPO Research Information

Provention Bio, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Provention Bio, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Provention Bio, Inc.	PRVB - NASDAQ	$4.00-$4.00	$4.00	$8.00	15.97 million	7/24/2018
Underwriter(s): MDB Capital Group
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2018-05-09 Terms Added 2018-05-29

Provention Bio, Inc. Quote & Chart - Click for current quote - PRVB

About Provention Bio, Inc. (adapted from Provention Bio, Inc. prospectus):
They are a clinical-stage biopharmaceutical company developing novel therapeutics aimed at intercepting and preventing immune-mediated diseases.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "PRVB" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.